A Study of Subcutaneous Tocilizumab as Monotherapy and/or in Combination With Non-Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Rheumatoid Arthritis
Clinical trial NCT01941095 · COMPLETED
Trial details
- NCT number
- NCT01941095
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-20
- Primary completion
- 2016-07-10
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.